CA2305183A1 - Traitement post-chirurgical a l'aide de dichloroacetate - Google Patents

Traitement post-chirurgical a l'aide de dichloroacetate Download PDF

Info

Publication number
CA2305183A1
CA2305183A1 CA002305183A CA2305183A CA2305183A1 CA 2305183 A1 CA2305183 A1 CA 2305183A1 CA 002305183 A CA002305183 A CA 002305183A CA 2305183 A CA2305183 A CA 2305183A CA 2305183 A1 CA2305183 A1 CA 2305183A1
Authority
CA
Canada
Prior art keywords
dichloroacetate
treatment
postsurgical
postsurgical treatment
permitting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002305183A
Other languages
English (en)
Other versions
CA2305183C (fr
Inventor
Gary Lopaschuk
Ruth Collins-Nakai
Koon Teo
Jason R.B. Dyck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2305183A1 publication Critical patent/CA2305183A1/fr
Application granted granted Critical
Publication of CA2305183C publication Critical patent/CA2305183C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002305183A 1997-10-03 1998-09-30 Traitement post-chirurgical a l'aide de dichloroacetate Expired - Fee Related CA2305183C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6091297P 1997-10-03 1997-10-03
US60/060,912 1997-10-03
PCT/US1998/020394 WO1999017763A1 (fr) 1997-10-03 1998-09-30 Traitement post-chirurgical a l'aide de dichloroacetate

Publications (2)

Publication Number Publication Date
CA2305183A1 true CA2305183A1 (fr) 1999-04-15
CA2305183C CA2305183C (fr) 2008-09-23

Family

ID=22032515

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002305183A Expired - Fee Related CA2305183C (fr) 1997-10-03 1998-09-30 Traitement post-chirurgical a l'aide de dichloroacetate

Country Status (4)

Country Link
JP (1) JP2001523635A (fr)
AU (1) AU9590698A (fr)
CA (1) CA2305183C (fr)
WO (1) WO1999017763A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063446A1 (fr) * 2004-12-15 2006-06-22 The Governors Of The University Of Alberta Procedes de cardioprotection utilisant le dichloroacetate en combinaison avec un inotrope

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727284B2 (en) 1997-10-03 2004-04-27 University Of Alberta Postsurgical treatment with dichloroacetate
US9820982B2 (en) 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
ATE395936T1 (de) * 2002-06-20 2008-06-15 Univ Alberta Dichloracetat in kombination mit kardioprotektiven oder hämodynamischen medikamenten
EP1908462A3 (fr) * 2002-06-20 2008-06-25 The Governors Of The University Of Alberta Dichloroacetate en combinaison avec des medicaments cardioprotecteurs ou hemodynamiques
US6693133B1 (en) 2002-10-07 2004-02-17 University Of Alberta Methods of cardioprotection using dichloroacetate in combination with an inotrope
AU2004315552A1 (en) * 2004-01-16 2005-08-25 The Governors Of The University Of Alberta Dichloroacetate in combination with an inotrope for cardioprotection
US9765393B2 (en) 2010-06-14 2017-09-19 University Of Florida Research Foundation, Inc. Methods, assays, and kits related to dichloroacetate (DCA)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703842B2 (en) * 1994-10-17 1999-04-01 Robert M. Bersin Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
US5587397A (en) * 1995-06-08 1996-12-24 Cypros Pharmaceutical Corporation Reduction of elevated blood lactate using twice-daily dichloroacetate

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063446A1 (fr) * 2004-12-15 2006-06-22 The Governors Of The University Of Alberta Procedes de cardioprotection utilisant le dichloroacetate en combinaison avec un inotrope
WO2007030944A3 (fr) * 2005-09-16 2007-05-03 Univ Alberta Methodes de cardioprotection consistant a utiliser du dichloroacetate combine a un inotrope

Also Published As

Publication number Publication date
JP2001523635A (ja) 2001-11-27
AU9590698A (en) 1999-04-27
CA2305183C (fr) 2008-09-23
WO1999017763A1 (fr) 1999-04-15

Similar Documents

Publication Publication Date Title
CA2231803A1 (fr) Extrait lipidique possedant une activite anti-inflammatoire
CA2294921A1 (fr) Levobupivacine et son utilisation
CA2400801A1 (fr) Traitement de l'insuffisance cardiaque congestive au moyen de sang autologue pretraite
AU3112899A (en) Rf diathermy and faradic muscle stimulation treatment
CA2058179A1 (fr) Systeme et methode de conditionnement electrophysiologique de base
AU3372895A (en) Therapeutic food composition and method to diminish blood sugar fluctuations
EP0808324A4 (fr) Compositions destinees au traitement et au diagnostic de maladies cardio-vasculaires et techniques correspondantes
CA2245661A1 (fr) Traitement de la sclerose en plaques
AU2463099A (en) Gabapentin and its derivatives for the treatment of muscular and skeletal pain
AU4777896A (en) Use of low dose amount of spironolactone for treatment of cardiovascular disease
EP0431074A4 (en) Disinfecting blood constituents, corneal and scleral tissue
CA2290482A1 (fr) Composition contenant du fructosane pour la prevention et le traitement du cancer du colon et procede preventif et therapeutique du cancer du colon
EP1736170A3 (fr) Agent pour le traitement de condition allergique ou hypersensitive
CA2091134A1 (fr) Agent therapeutique contre les risques d'avortement
AU2229695A (en) Cardiac pacemaker with physiological control and method
EP1064855A4 (fr) Aliments, traitements medicaux et methodes visant a favoriser la croissance de (lactobacillus bifidus), a prevenir les allergies et a reduire le taux de cholesterol chez l'homme
AU1867297A (en) Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders
AU6777596A (en) Treatment of human prostate disease with beta-lapachone derivatives
AU7053894A (en) Enzymatic rna molecules and their application in the treatment of fibrosis and fibrous tissue disease
FR2687179B1 (fr) L'arc, la voute, la croisee d'arcs et la coupole destines a etre habites et a l'activite humaine.
CA2287903A1 (fr) Traitement de pathologies par un jeu video commande par microprocesseur
EP0668771A4 (fr) Traitement des maladies autoimmunes par induction d'une tolerance des cellules, des tissus et des organes.
WO1998025594A3 (fr) Nouveau traitement
FR2749509B1 (fr) Procede de preparation d'une pate de soin epilatoire de maniere progressivement definitive avec effet de massage, desincrustante et astringente, hemostatique et apaisante
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed